JNM: FLT-PET aids prognosis of glioma patients

December 4, 2012

PET imaging with F-18 fluorothymidine (FLT) can noninvasively and accurately provide tumor-specific details to guide the management of patients with gliomas, according to two studies in the December issue of the Journal of Nuclear Medicine.

Precise assessment of tumor grade and cell proliferation plays a major role in determining the most appropriate treatment and predicting overall survival in glioma patients.